These findings indicated that B7-H5 is an important negative checkpoint regulator in the TME, but the clinical significance of the B7-H5 expression in CRC and the role of B7-H5 in the TME remain to be elucidated. The gene discussed is VSIR; the disease is colorectal carcinoma.